Objective To observe and compare the main side effects of chemotherapy with Lobaplatin plus Paclitaxel or Cisplatin plus Paclitaxel for gynecologic malignancies.Method Sixty advanced gynecological cancer patients admitted to our hospital from January 2012 to August 2015 were selected retrospectively. Among them, 30 patients received 3~6 cycles of chemotherapy with lobaplation plus paclitaxel, which is referred to as lobaplatin group, while others received 3~5 cycles of chemotherapy with cisplatin plus pacli...